These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25807347)

  • 1. Bone and morphogenetic protein signalling and muscle mass.
    Sartori R; Sandri M
    Curr Opin Clin Nutr Metab Care; 2015 May; 18(3):215-20. PubMed ID: 25807347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFβ and BMP signaling in skeletal muscle: potential significance for muscle-related disease.
    Sartori R; Gregorevic P; Sandri M
    Trends Endocrinol Metab; 2014 Sep; 25(9):464-71. PubMed ID: 25042839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMPs and the muscle-bone connection.
    Sartori R; Sandri M
    Bone; 2015 Nov; 80():37-42. PubMed ID: 26036170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators.
    Souza TA; Chen X; Guo Y; Sava P; Zhang J; Hill JJ; Yaworsky PJ; Qiu Y
    Mol Endocrinol; 2008 Dec; 22(12):2689-702. PubMed ID: 18927237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP signaling controls muscle mass.
    Sartori R; Schirwis E; Blaauw B; Bortolanza S; Zhao J; Enzo E; Stantzou A; Mouisel E; Toniolo L; Ferry A; Stricker S; Goldberg AL; Dupont S; Piccolo S; Amthor H; Sandri M
    Nat Genet; 2013 Nov; 45(11):1309-18. PubMed ID: 24076600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific targeting of TGF-β family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease.
    Chen JL; Walton KL; Hagg A; Colgan TD; Johnson K; Qian H; Gregorevic P; Harrison CA
    Proc Natl Acad Sci U S A; 2017 Jun; 114(26):E5266-E5275. PubMed ID: 28607086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulation by members of the TGFβ superfamily.
    Chen W; Ten Dijke P
    Nat Rev Immunol; 2016 Nov; 16(12):723-740. PubMed ID: 27885276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of myostatin and bone morphogenetic proteins in muscular disorders.
    Tsuchida K
    Expert Opin Biol Ther; 2006 Feb; 6(2):147-54. PubMed ID: 16436040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβ.
    Lamar KM; Bogdanovich S; Gardner BB; Gao QQ; Miller T; Earley JU; Hadhazy M; Vo AH; Wren L; Molkentin JD; McNally EM
    PLoS Genet; 2016 May; 12(5):e1006019. PubMed ID: 27148972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.
    Morvan F; Rondeau JM; Zou C; Minetti G; Scheufler C; Scharenberg M; Jacobi C; Brebbia P; Ritter V; Toussaint G; Koelbing C; Leber X; Schilb A; Witte F; Lehmann S; Koch E; Geisse S; Glass DJ; Lach-Trifilieff E
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12448-12453. PubMed ID: 29109273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFβ Superfamily Members Mediate Androgen Deprivation Therapy-Induced Obese Frailty in Male Mice.
    Pan C; Singh S; Sahasrabudhe DM; Chakkalakal JV; Krolewski JJ; Nastiuk KL
    Endocrinology; 2016 Nov; 157(11):4461-4472. PubMed ID: 27611336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myostatin/activin pathway antagonism: molecular basis and therapeutic potential.
    Han HQ; Zhou X; Mitch WE; Goldberg AL
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2333-47. PubMed ID: 23721881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of avian cardiac myogenesis by activin/TGFbeta and bone morphogenetic proteins.
    Ladd AN; Yatskievych TA; Antin PB
    Dev Biol; 1998 Dec; 204(2):407-19. PubMed ID: 9882479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activin A/bone morphogenetic protein (BMP) chimeras exhibit BMP-like activity and antagonize activin and myostatin.
    Korupolu RV; Muenster U; Read JD; Vale W; Fischer WH
    J Biol Chem; 2008 Feb; 283(7):3782-90. PubMed ID: 18056265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myostatin is a novel tumoral factor that induces cancer cachexia.
    Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
    Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.
    Tsuchida K; Nakatani M; Uezumi A; Murakami T; Cui X
    Endocr J; 2008 Mar; 55(1):11-21. PubMed ID: 17878607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins.
    Sidis Y; Mukherjee A; Keutmann H; Delbaere A; Sadatsuki M; Schneyer A
    Endocrinology; 2006 Jul; 147(7):3586-97. PubMed ID: 16627583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activins, myostatin and related TGF-beta family members as novel therapeutic targets for endocrine, metabolic and immune disorders.
    Tsuchida K
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun; 4(2):157-66. PubMed ID: 15180456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression.
    Nana AW; Yang PM; Lin HY
    Asian Pac J Cancer Prev; 2015; 16(16):6813-23. PubMed ID: 26514451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.